Publication:
VAMP2 is implicated in the secretion of antibodies by human plasma cells and can be replaced by other synaptobrevins.

dc.contributor.authorGómez-Jaramillo, Laura
dc.contributor.authorRomero-García, Raquel
dc.contributor.authorJiménez-Gómez, Gema
dc.contributor.authorRiegle, Lisa
dc.contributor.authorRamos-Amaya, Ana Belén
dc.contributor.authorBrieva, José Antonio
dc.contributor.authorKelly-Worden, Marie
dc.contributor.authorCampos-Caro, Antonio
dc.date.accessioned2023-01-25T08:36:27Z
dc.date.available2023-01-25T08:36:27Z
dc.date.issued2016-09-12
dc.description.abstractThe production and secretion of antibodies by human plasma cells (PCs) are two essential processes of humoral immunity. The secretion process relies on a group of proteins known as soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs), which are located in the plasma membrane (t-SNAREs) and in the antibody-carrying vesicle membrane (v-SNARE), and mediate the fusion of both membranes. We have previously shown that SNAP23 and STX4 are the t-SNAREs responsible for antibody secretion. Here, using human PCs and antibody-secreting cell lines, we studied and characterized the expression and subcellular distribution of vesicle associated membrane protein (VAMP) isoforms, demonstrating that all isoforms (with the exception of VAMP1) are expressed by the referenced cells. Furthermore, the functional role in antibody secretion of each expressed VAMP isoform was tested using siRNA. Our results show that VAMP2 may be the v-SNARE involved in vesicular antibody release. To further support this conclusion, we used tetanus toxin light chain to cleave VAMP2, conducted experiments to verify co-localization of VAMP2 in antibody-carrying vesicles, and demonstrated the coimmunoprecipitation of VAMP2 with STX4 and SNAP23 and the in situ interaction of VAMP2 with STX4. Taken together, these findings implicate VAMP2 as the main VAMP isoform functionally involved in antibody secretion.
dc.identifier.doi10.1038/cmi.2016.46
dc.identifier.essn2042-0226
dc.identifier.pmcPMC6052834
dc.identifier.pmid27616736
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052834/pdf
dc.identifier.unpaywallURLhttps://www.nature.com/articles/cmi201646.pdf
dc.identifier.urihttp://hdl.handle.net/10668/10434
dc.issue.number4
dc.journal.titleCellular & molecular immunology
dc.journal.titleabbreviationCell Mol Immunol
dc.language.isoen
dc.organizationHospital Universitario Puerta del Mar
dc.page.number353-366
dc.pubmedtypeJournal Article
dc.rights.accessRightsopen access
dc.subjectVAMP proteins
dc.subjectexocytosis
dc.subjecthuman
dc.subjectimmunoglobulin
dc.subjectplasma cells
dc.subject.meshAntibodies
dc.subject.meshCell Line
dc.subject.meshCytoplasmic Vesicles
dc.subject.meshGene Silencing
dc.subject.meshHumans
dc.subject.meshImmunoglobulin E
dc.subject.meshPlasma Cells
dc.subject.meshProtein Domains
dc.subject.meshProtein Transport
dc.subject.meshQa-SNARE Proteins
dc.subject.meshQb-SNARE Proteins
dc.subject.meshQc-SNARE Proteins
dc.subject.meshRNA, Small Interfering
dc.subject.meshTetanus Toxin
dc.subject.meshVesicle-Associated Membrane Protein 2
dc.titleVAMP2 is implicated in the secretion of antibodies by human plasma cells and can be replaced by other synaptobrevins.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number15
dspace.entity.typePublication

Files